Strategic Leadership in Global Biotech

Biotech is a booming industry. It is going global at an unprecedented rate, most notably in Asia and the Pacific. What are the strategic implications of these developments?

This seminar seeks to provide a range of answers to this question, and, in doing so, direct attention to the challenges that the globalization of biotech has for the leaders in Scandinavian biotech.

The seminar will have two keynote presentations and a roundtable with panelists from business and CBS.

Opening Remarks and Introduction

Professor Susse Georg, Department of Organization, CBS.

Keynote Speakers

Rasmus Nelund, Partner, Passion & Discipline

“The sexappeal of strategic leadership in Biotech”.

Professor David Finegold, Dean School of Management and Labor Relations, Rutgers, The State University of New Jersey

“Pharma Goes Hollywood: Emerging Business Models in the Bioscience Industry”.

Discussion with keynote speakers

Coffee break

Roundtable on the challenges of strategic leadership

• “The Medicon Valley Way of Management”, Niels Gerner, Medicon Valley

• “Emerging Strategies in Early Stage Companies”, Trine Winterøe , CEO, TecTra

• Professor Finn Vallentin, CBS, on the importance of company origin and its effect on performance

• Associate Professor, Maja Horst, on managing expectations: bioscience in society

Moderator: Henrik Christensen, CEO, Kem-En-Tec A/S

This seminar is in memory of Professor Jesper Norus, who died in September 2006. Jesper Norus was a researcher internationally recognised for his work on strategic leadership and networks in the biotech industry

Registration

Registration is necessary (limited number of seats), so please send an e-mail to Joan Knudsen, jk.ioa@cbs.dk no later then the 7th of December 2007, if you want to attend the conference.